OptimizeRx Corp (OPRX) › Capital ExpendituresOptimizeRx Corp (OPRX) — Capital ExpendituresAnnual figures by period end, from SEC filings.2010-12-31: -$1.2K2011-12-31: $13.1K2012-12-31: $2.2K2013-12-31: $02014-12-31: $7.0K2015-12-31: $2.0K2016-12-31: $178.4K2017-12-31: $42.2K2018-12-31: $34.4K2019-12-31: $87.7K2020-12-31: $68.0K2021-12-31: $100.3K2022-12-31: $81.0K2023-12-31: $87.0K2024-12-31: $112.0K2025-12-31: $58.0K$58.0K2010-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$58.0K-48.2%2026-03-12From 2025-01-012024-12-31$112.0K+28.7%2026-03-12From 2024-01-012023-12-31$87.0K+7.4%2025-03-20From 2023-01-012022-12-31$81.0K-19.3%2024-04-15From 2022-01-012021-12-31$100.3K+47.4%2023-03-10From 2021-01-012020-12-31$68.0K-22.4%2023-03-10From 2020-01-012019-12-31$87.7K+155.3%2021-03-08From 2019-01-012018-12-31$34.4K-18.7%2020-03-26From 2018-01-012017-12-31$42.2K-76.3%2019-03-12From 2017-01-012016-12-31$178.4K+8621.1%2018-03-08From 2016-01-012015-12-31$2.0K-70.7%2017-03-08From 2015-01-012014-12-31$7.0K—2016-03-15From 2014-01-012013-12-31$0-100.0%2014-03-31From 2013-01-012012-12-31$2.2K-83.0%2014-03-31From 2012-01-012011-12-31$13.1K—2013-03-12From 2011-01-012010-12-31-$1.2K—2012-03-30From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)